Leukemia is cancer of the blood-forming tissue — usually the bone marrow — where abnormal white blood cells multiply out of control and crowd out the healthy cells you need to carry oxygen, fight infection, and clot. There are four main types: acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). “Acute” means blast cells are piling up fast and treatment usually starts within days; “chronic” means the disease can smolder for years, and some patients are simply monitored.
Management depends almost entirely on which type you have. CML is now controlled with a daily pill for most patients. Early-stage CLL often needs no treatment at all. AML and ALL typically require intensive chemotherapy, sometimes followed by a stem cell transplant. Below is the practical breakdown — who gets each type, what the numbers mean, and what treatment actually looks like. For a broader orientation, start with our leukemia guide.
The Four Types at a Glance
| Type | Typical Age | Pace | First-Line Treatment | 5-Year Survival (approx.) |
|---|---|---|---|---|
| ALL | Peak 2–5 yrs; second rise after 50 | Days to weeks | Multi-phase chemo (2–3 yrs), CNS prophylaxis | ~90% children, ~40% adults |
| AML | Median ~68 yrs | Days to weeks | Induction chemo ± transplant; azacitidine + venetoclax if unfit | ~30% overall |
| CLL | Median ~70 yrs | Years | Watch and wait; BTK or BCL-2 inhibitors when symptomatic | ~88% |
| CML | Median ~64 yrs | Years | Tyrosine kinase inhibitor (oral, daily) | >70%, near-normal lifespan on therapy |
Roughly 60,000 Americans are diagnosed with leukemia each year. Men are affected more often than women across all four subtypes — a pattern still not fully explained, though occupational chemical exposure likely contributes.
Symptoms: What Actually Sends People to the Doctor
Leukemia symptoms come from what’s missing, not from what’s growing. As blasts fill the bone marrow, production of red cells, platelets, and functional neutrophils collapses.
- Anemia symptoms: fatigue that sleep doesn’t fix, breathlessness on stairs, pallor, pounding heartbeat
- Low platelets: bruises appearing without injury, pinpoint red dots (petechiae) on the shins, nosebleeds, gum bleeding, heavy periods
- Low functional neutrophils: recurrent fevers, mouth ulcers, infections that keep coming back or don’t clear on antibiotics
- Disease bulk: painless swollen lymph nodes, early fullness after eating (enlarged spleen), bone or joint pain — common in childhood ALL
- Systemic: drenching night sweats, unexplained weight loss over 6 months
CLL is frequently found by accident — a routine blood count shows a lymphocyte count of 20,000/µL in someone who feels perfectly well. That’s a legitimate presentation, not a missed diagnosis.
When to See a Doctor
Book an appointment within a week if you have unexplained bruising or bleeding, a lymph node larger than 1.5 cm that persists beyond two to three weeks, drenching night sweats, or fatigue plus recurrent infection.
Go to the emergency department now if you have a fever above 38°C with known low white cells, bleeding that won’t stop, sudden severe headache or confusion, or breathlessness at rest. Very high white cell counts (over 100,000/µL) can cause sludging in small vessels — a true emergency called hyperleukocytosis.
Causes and Risk Factors
Most leukemia arises from acquired mutations in a single blood stem cell — bad luck at the DNA level, not something you did. Established risk factors include:
- Prior chemotherapy or radiotherapy (alkylating agents, topoisomerase II inhibitors) — therapy-related AML typically appears 2–7 years later
- Benzene exposure — refineries, rubber manufacturing, some solvents
- Ionizing radiation at high doses
- Tobacco smoking — a modifiable contributor to AML risk
- Genetic syndromes — Down syndrome, Fanconi anemia, Li-Fraumeni
- Age — the single strongest factor for AML, CLL, and CML
Specific chromosomal events drive specific diseases. The Philadelphia chromosome, t(9;22), creates the BCR-ABL1 fusion gene that defines CML. The t(15;17) translocation of acute promyelocytic leukemia produces a subtype that is both a medical emergency and one of the most curable cancers in medicine.
How Leukemia Is Diagnosed
Diagnosis moves in three steps, usually completed within 48–72 hours for suspected acute disease.
1. Complete Blood Count with Differential
The white cell count may be sky-high, normal, or paradoxically low. What matters is the presence of blasts on the smear plus suppression of other lines. Hemoglobin below 12 g/dL (women) or 13.5 g/dL (men), platelets under 150,000/µL, and an absolute neutrophil count under 1,500/µL together are a red flag pattern. Our overview of abnormal blood conditions explains how these values interact.
2. Bone Marrow Aspirate and Biopsy
The defining threshold: 20% or more blasts in marrow or peripheral blood establishes acute leukemia under WHO criteria. Certain genetic abnormalities are diagnostic regardless of blast percentage.
3. Flow Cytometry, Cytogenetics, and Molecular Testing
Immunophenotyping separates lymphoid from myeloid lineage. Karyotype and next-generation sequencing identify FLT3, NPM1, IDH1/2, TP53, and BCR-ABL1 — findings that dictate both prognosis and which targeted drug you receive. For a deeper walkthrough, see our guide to the diagnosis of leukemia.
What Else It Could Be
Myelodysplastic syndromes, aplastic anemia, lymphoma with marrow involvement, severe infection, and B12 deficiency can all mimic leukemia on a blood count. Distinguishing them requires the full panel — which is why a single abnormal CBC is a reason for further testing, not a diagnosis. Patients and families navigating this stage often find our primer on hematological disorders useful.
Treatment: Type by Type
Acute Lymphoblastic Leukemia
Treatment runs 2–3 years across induction, consolidation, and maintenance, with intrathecal chemotherapy to protect the central nervous system. Philadelphia-positive cases add a TKI. Blinatumomab and CAR T-cell therapy have changed the outlook for relapsed disease. See our detailed look at B-cell ALL survival rates and treatment strategies.
Acute Myeloid Leukemia
Fit patients receive “7+3” induction (cytarabine plus an anthracycline). Older or unfit patients often do better with azacitidine plus venetoclax. Allogeneic stem cell transplant is offered to intermediate- and high-risk patients in first remission. Targeted agents — midostaurin for FLT3, ivosidenib for IDH1 — are added based on molecular results.
Chronic Lymphocytic Leukemia
Early-stage, asymptomatic CLL is monitored, not treated; treating early does not extend life. Therapy begins for progressive cytopenias, bulky nodes, or severe symptoms, and now centres on BTK inhibitors and venetoclax rather than chemotherapy.
Chronic Myeloid Leukemia
The success story of modern oncology. Daily imatinib, dasatinib, or nilotinib brings most patients to deep molecular remission, and selected patients with sustained response can attempt treatment-free remission under close monitoring. Additional treatment detail is covered in our guide to leukemia diagnosis and management.
Frequently Asked Questions
Can a routine blood test detect leukemia?
Often, yes. A CBC with differential will usually show abnormal counts or circulating blasts. But a normal CBC does not completely exclude leukemia, and abnormal counts far more often reflect infection or deficiency than cancer.
Is leukemia hereditary?
The vast majority of cases are not inherited. A family history in a first-degree relative modestly raises CLL risk, and inherited syndromes like Li-Fraumeni increase risk — but most patients have no family history at all.
How fast does acute leukemia progress without treatment?
Untreated acute leukemia is typically fatal within weeks to a few months, usually from infection or hemorrhage. This is why suspected acute leukemia is admitted the same day rather than scheduled for an outpatient workup.
Can leukemia be cured?
Yes, for many patients. Childhood ALL is cured in roughly 9 of 10 cases. Acute promyelocytic leukemia has cure rates above 90% with ATRA-based therapy. CML is usually controlled rather than cured, but with a life expectancy approaching normal.
Does leukemia cause bone pain?
It can, especially in children with ALL, where marrow expansion causes aching in the long bones, pelvis, or sternum. Persistent bone pain with fatigue or bruising warrants a blood count.
Key Takeaways
- Four main types — ALL, AML, CLL, CML — behave so differently that “leukemia” alone tells you almost nothing about prognosis
- 20% blasts in blood or marrow defines acute leukemia and triggers urgent treatment
- Bruising, recurrent infection, and unexplained fatigue occurring together deserve a same-week CBC
- Molecular testing is not optional — it determines which targeted drug you get and whether transplant is recommended
- Early-stage CLL is watched, not treated; CML is managed with a daily oral pill
This article is educational and does not replace individual medical advice. Discuss any abnormal blood results or persistent symptoms with a qualified clinician.
